Increased plasma levels of thioredoxin in patients with coronary spastic angina

Insights

Plasma thioredoxin levels are significantly higher in patients with coronary artery spasm, indicating it is a risk factor. Increased thioredoxin is linked to more frequent angina attacks, suggesting a role in disease activity.

Area of Science:

  • Cardiology
  • Biochemistry
  • Internal Medicine

Background:

  • Coronary artery spasm, a condition causing chest pain, requires better diagnostic markers.
  • Thioredoxin is a protein with known roles in oxidative stress and inflammation.

Purpose of the Study:

  • To investigate the association between plasma thioredoxin levels and coronary artery spasm.
  • To identify thioredoxin as a potential biomarker for coronary artery spasm.

Main Methods:

  • Plasma thioredoxin levels were measured in 170 patients undergoing coronary arteriography.
  • Patients were categorized into coronary spastic angina (n=84) and chest pain syndrome (n=86) groups.
  • Statistical analyses, including multiple logistic regression, were performed.

Main Results:

  • Plasma thioredoxin levels were significantly higher in the coronary spastic angina group compared to the chest pain syndrome group (40.7 ± 4.1 vs. 18.2 ± 1.1 ng/ml, p<0.0001).
  • Elevated thioredoxin levels correlated with increased angina attack frequency (p=0.0004).
  • Higher plasma thioredoxin (RR 14.8) and current smoking (RR 3.39) were independent risk factors for coronary spasm.

Conclusions:

  • Plasma thioredoxin levels are elevated in patients with coronary artery spasm.
  • Thioredoxin may serve as a valuable biomarker for diagnosing and assessing the activity of coronary artery spasm.
  • Both plasma thioredoxin and smoking are independent risk factors for coronary artery spasm.

Related Concept Videos

Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Antianginal Drugs: Nitrates and &#946;-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Angina I: Introduction01:30

Angina I: Introduction

Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...